Equillium to Participate in Upcoming Investor Conferences
Rhea-AI Summary
Equillium (Nasdaq: EQ) said members of management will participate in two investor events in November 2025: a company presentation and 1x1 meetings at the Stifel Healthcare Conference on Wednesday, November 12, 2025, 3:20–3:50 PM EDT, and 1x1 meetings at the Jefferies Global Healthcare Conference in London from November 18–20, 2025.
Management will meet with registered investors and the public can listen to a live webcast of the Stifel presentation via the Events & Presentations page under Investor Relations at equilliumbio.com. An archived replay of both presentations will be available for 90 days.
Positive
- None.
Negative
- None.
News Market Reaction 12 Alerts
On the day this news was published, EQ declined 7.10%, reflecting a notable negative market reaction. Argus tracked a peak move of +4.2% during that session. Argus tracked a trough of -13.2% from its starting point during tracking. Our momentum scanner triggered 12 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $7M from the company's valuation, bringing the market cap to $86M at that time.
Data tracked by StockTitan Argus on the day of publication.
LA JOLLA, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that management will participate in the following upcoming investor conferences:
| Stifel Healthcare Conference | |
| Format: | Company Presentation & 1x1 Meetings |
| Date: | Wednesday, November 12, 2025 |
| Time: | 3:20-3:50 PM EDT |
| Jefferies Global Healthcare Conference in London | |
| Format: | 1x1 Meetings |
| Date: | Tuesday, November 18 – Thursday, November 20, 2025 |
Members of the Equillium management team will be available to participate in meetings with investors who are registered to attend the conference.
Investors and the general public are invited to listen to a live webcast of the presentation on the Events & Presentations page, located under the Investor Relations section on equilliumbio.com. An archived replay of both presentations will be available for 90 days.
About Equillium
Equillium is a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need. The company’s pipeline consists of several novel immunomodulatory assets and product platform targeting immuno-inflammatory pathways.
For more information, visit www.equilliumbio.com.
Investor Contact
PJ Kelleher
LifeSci Advisors, LLC
+1-617-430-7579
pkelleher@lifesciadvisors.com
FAQ
When will Equillium (EQ) present at the Stifel Healthcare Conference?
How can I watch Equillium's (EQ) Stifel presentation webcast?
Will Equillium (EQ) attend the Jefferies Global Healthcare Conference in London?
How long will Equillium (EQ) presentation replays be available?
Do I need to register to meet Equillium (EQ) management at these conferences?
Where can investors find details about Equillium (EQ) conference appearances?
